| CAT. No. | MRL-C45001 |
| CAS. No. | 183133-96-2 |
| Mol. Formula | C45H57NO14 |
| Mol. Weight | 835.9 |
| Synonyms | NA |
| Chemical Name | (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]be |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | In Stock |
Cabazitaxel works by inhibiting microtubule depolymerization, disrupting cell division and leading to cancer cell death. It is often used when prostate cancer has not responded to other treatments. Cabazitaxel is administered through intravenous infusion and requires medical supervision due to potential side effects, including neutropenia and gastrointestinal issues. The drugs chemistry involves its modification from paclitaxel, optimizing its activity against resistant cancer cells. Buy high quality Cabazitaxel from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Cabazitaxel